# Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS

> **NCT02925975** · PHASE4 · UNKNOWN · sponsor: **Changqing Yang** · enrollment: 100 (actual)

## Conditions studied

- Portal Hypertension
- Cirrhosis

## Interventions

- **DRUG:** Carvedilol
- **DEVICE:** 3D-vHPS
- **PROCEDURE:** Routine endoscopic procedures

## Key facts

- **NCT ID:** NCT02925975
- **Lead sponsor:** Changqing Yang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02925975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02925975, "Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02925975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*